In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay

Leukemia Research

Volumn 24, Issue 5, 2000, Pages 445-452

  Möllgård, Lars ^a   Tidefelt, Ulf ^b   Sundman Engberg, Britt ^a   Löfgren, Christina ^a   Paul, Christer ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

Bioluminiscence ATP assay; Chemosensitivity; Cytotoxicity; Drug resistance; Myeloid leukemia

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMSACRINE; CYTARABINE; CYTOSTATIC AGENT; DAUNORUBICIN; ETOPOSIDE; GYRASE INHIBITOR; IDARUBICIN; MITOXANTRONE; RETINOIC ACID; TIOGUANINE; VALSPODAR;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ARTICLE; BIOASSAY; BIOLUMINESCENCE; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADENOSINE TRIPHOSPHATE; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL ASSAY; CELL SURVIVAL; DAUNORUBICIN; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA, MYELOID; LUMINESCENT MEASUREMENTS; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0342424370     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(00)00003-5     Document Type: Article

References (34)

1. Hamburger A.W., Salmon S.E. Primary bioassay of human stem cells. Science. 197:1977;461.
2. Cree I.A., Pazzagli M., Mini E., Mazzei T., Hunter E.M., Sutherland L.A., Pinzani P., Gerli A., Andreotti P.E. Methotrexate chemosensitivity by ATP luminiscence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay. Anticancer Drugs. 6:1995;398.
3. Delmer A., Marie J.P., Thevenin D., Suberville A.M., Zittoun R. Treatment of relapsing and refractory adult acute myeloid leukemia according to in vitro clonogenic leukemic cell drug sensitivity. Leuk. Lymphoma. 10:1993;67.
4. Weisenthal L.M., Marsden J.A., Dill P.L., Macaluso C.K. A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res. 43:1983;749.
5. Bird M.C., Bosanquet A.G., Forskitt S., Gillby E.D. Semi-micro adaption of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haemtological malignancies. Leuk. Res. 10:1986;445.
6. Wilbur D.W., Camacho E.S., Hilliard D.A., Dill P.L., Weisenthal L.M. Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill. Br. J. Cancer. 65:1992;27.
7. Bosanquet A.G., Copplestone J.A., Johnson S.A., Smith A.G., Povey S.J., Orchard J.A., Oscier D.G. Response to cladribine in previosly treated patients with chronic lymphocytic leukemia identified by ex vivo assessment of drug sensitivity by DiSC assay. Br. J. Haematol. 106:1999;474.
8. Tidefelt U., Sundman-Engberg B., Rhedin A.-S., Paul C. In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations. Eur. J. Haematol. 43:1989;374.
9. Staib P., Lathan B., Schinkothe T., Wiedenmann S., Pantke B., Dimski T., Voliotis V., Diehl V. Prognosis in adult AML is precisely predicted by the DiSC-assay using the chemosensitivity-index Ci. Adv. Exp. Med. Biol. 457:1999;437.
10. Pieters R., Huismans D.R., Leyva A., Veerman A.J. Comparison of a rapid automated MTT assay with a dye-exclusion assay for chemosensitivity testing of childhood leukemia. Br. J. Cancer. 59:1989;217.
11. Kaspers G.J., Veerman A.J., Pieters R., Van Zantwijk C.H., Smets L.A., Van Wering E.R., Van Der Does-Van Den Berg A. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood. 90:1997;2723.
12. Norgaard J.M., Langkjer S.T., Palshof T., Clausen N., Pedersen B., Hokland P. Relation of blast cell survival and proliferation to chemotherapy resistance in AML. Br. J. Haematol. 93:1996;888.
13. Norgaard J.M., Olesen G., Kristensen J.S., Pedersen B., Hokland P. Leukemia cell drug resistance and prognostic factors in AML. Eur. J. Haematol. 63:1999;219.
14. Stute N., Kohler T., Lehmann L., Wetzstein W., Ehninger G. Drug resistance testing of acute myeloid leukemia in adults using the MTT assay. Adv. Exp. Med. Biol. 457:1999;445.
15. Klumper E., Ossenkoppele G.J., Pieters R., Huismans R., Loonen A.H., Rottier A., Westra G., Veerman A.J. In vitro resistance to cytosin arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia. Br. J. Haematol. 93:1996;903.
16. Larsson R., Kristensen J., Sanberg C., Nygren P. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia using a fluorometric microculture cytotoxicity assay (FMCA). Int. J. Cancer. 50:1992;177.
17. Kristensen J., Jonsson B., Sundström C., Nygren P., Larsson R. In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia. Med. Oncol. Tumor. Pharmacother. 9:1992;65.
18. Lönnerholm G., Frost B.M., Larsson R., Liliemark E., Nygren P., Peterson C. In vitro cytotoxic drug activity and in vivo pharmacokinetics in childhood acute myeloid leukemia. Adv. Exp. Med. Biol. 457:1999;429.
19. Kuzmits R., Aiginger P., Müller M.M., Steurer G., Linkesch W. Assessment of sensitivity of leukemic cells to cytotoxic drugs by bioluminescence measurement of ATP in cultured cells. Clin. Sci. 71:1986;81.
20. Kangas L., Grönroos M., Nieminen A.L. Bioluminiscence of celullar ATP: a new method for evaluating cytotoxic drugs in vitro. Med. Biol. 62:1984;338.
21. Thore A., Ånséhn S., Lundin A., Bergman S. Detection of bacteriuria by luciferase assay of adenosine triphosphate. J. Clin. Microbiol. 1:1975;1.
22. Lundin A., Hasenson M., Persson J., Pousette Å. Estimation of biomass in growing cell lines by adenosine triphosphate assay. Methods Enzymol. 133:1986;27.
23. Rhedin A.S., Tidefelt U., Jonsson K., Lundin A., Paul C. Comparision of a bioluminescence assay with differential staining cytotoxicity for cytostatic drug testing in vitro in human leukemic cells. Leuk. Res. 17:1993;271.
24. Andreotti P.E., Cree I.A., Kurbacher C.M., Hartmann D.M., Linder D., Harel G., Gleiberman I., Caruso P.A., Ricks S.H., Untch M. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminiscence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Res. 55:1995;5276.
25. Kurbacher C.M., Bruckner H.W., Cree I.A., Kurbacher J.A., Wilhelm L., Poch G., Indefrei D., Mallman P., Andreotti P.E. Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trial. Clin. Cancer Res. 3:1997;1527.
26. Cree IA, Neale MH, Myatt NE, de Takats PG, Hall P, Grant J, Kurbacher CM, Reinhold U, Neuber K, MacKie RM, Chana J, Weaver PC, Khoury GG, Sartori C, Andreotti. Heterogeneity of chemosensitivity of metastatic cutaneous melanoma, Anticancer Drugs 1999;10:437.
27. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann. Intern. Med. 103:1985;620.
28. Böyum A. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran and ficoll as erythrocyte aggregating agents. Scand. J. Clin. Lab. Invest. 21:1968;31.
29. Paul C., Peterson C., Gahrton G., Lockner D. Uptake of free and DNA-bound daunorubicin and doxorubicin in human leukemic cells. Cancer Chemother. Pharmacol. 2:1979;49.
30. Pallavicini M.G. Cytosine arabinoside: molecular, pharmacokinetic and cytokinetic considerations. Pharmacol. Ther. 25:1984;207.
31. Vidriales M.B., Orfao A., López-Berges M.C., González M., López-Macedo A., Ciudad J., López A., García M.A., Hernández J., Borrego D., San Miguel J.F. Prognostic value of S-phase cells in AML patients. Br. J. Haematol. 89:1995;342.
32. McKenna S.L., Padau R.A. Multidrug resistance in leukemia (review). Br. J. Haematol. 96:1997;659.
33. Bird M.C., Bosanquet A.G., Forskitt S., Gillby E.D. Longterm comparison of results of a drug-sensitivity assay in vitro with patient response in lymphatic neoplasms. Cancer. 61:1988;1104.
34. Campana D., Manabe A., Evans W.E. Stroma-Supported Immuncytometric Assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Leukemia. 7:1993;482.